Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in SUSTAIN 1--5 trials
Journal article published in 2018 by
Bo Ahrén,
Stephen L. Atkin,
Guillaume Charpentier,
Mark L. Warren,
John Ph Wilding,
Sune Birch,
Anders Gaarsdal Holst 
,
Lawrence A. Leiter
,
Lawrence A. Leiter
